Condition: Breast Cancer · Sponsor: Agendia
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry. All patients with stage I to III breast cancer who receive MammaPrint® and BluePrint testing on a primary breast tumor are eligible for entry into the FLEX Registry, which is intended to enable additional study arms at low incremental effort and cost. FLEX Registry will utilize an adaptive design, where additional targeted substudies and arms can be added after the initial study is opened.
This description comes directly from the study's public registry record.
Michelle Landon, MS, CGC · 801-633-8215 · michelle.landon@agendia.com
Always discuss trial participation with your own doctor first.
| CHS Grandview | Birmingham, Alabama, United States | Completed |
| Providence Alaska Medical Center | Anchorage, Alaska, United States | Recruiting |
| Arizona Oncology Associates, PC | Phoenix, Arizona, United States | Recruiting |
| Arizona Oncology Associates, PC - HOPE | Tucson, Arizona, United States | Recruiting |
| Adventist Health - Bakersfield | Bakersfield, California, United States | Recruiting |
| Comprehensive Cancer Center at Desert Regional Medical Center | Palm Springs, California, United States | Recruiting |
| North Valley Breast Clinic | Redding, California, United States | Recruiting |
| UCSF Breast Care Center | San Francisco, California, United States | Recruiting |
| Valley Breast Care | Van Nuys, California, United States | Recruiting |
| Rocky Mountain Cancer Centers | Aurora, Colorado, United States | Recruiting |
| University of Colorado Cancer Center | Aurora, Colorado, United States | Recruiting |
| Comprehensive Breast Care of Denver | Denver, Colorado, United States | Recruiting |
+ 122 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.